Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5084760010 | Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5084761014 | Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5084762019 | Aluminum hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxethazaine 2 mg/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Conventional release oral suspension | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Laxative therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Oxetacaine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Oxetacaine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Aluminium hydroxide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Aluminium hydroxide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR